Feldman HH

References (7)

Title : Memantine and Acetylcholinesterase Inhibitor Use in Alzheimer's Disease Clinical Trials: Potential for Confounding by Indication - Huisa_2019_J.Alzheimers.Dis_67_707
Author(s) : Huisa BN , Thomas RG , Jin S , Oltersdorf T , Taylor C , Feldman HH
Ref : J Alzheimers Dis , 67 :707 , 2019
Abstract : Huisa_2019_J.Alzheimers.Dis_67_707
ESTHER : Huisa_2019_J.Alzheimers.Dis_67_707
PubMedSearch : Huisa_2019_J.Alzheimers.Dis_67_707
PubMedID: 30636733

Title : 16-Year Survival of the Canadian Collaborative Cohort of Related Dementias - Lichtenstein_2018_Can.J.Neurol.Sci__1
Author(s) : Lichtenstein ML , Fallah N , Mudge B , Hsiung GR , Foti D , Beattie BL , Feldman HH
Ref : Can Journal of Neurology Sci , :1 , 2018
Abstract : Lichtenstein_2018_Can.J.Neurol.Sci__1
ESTHER : Lichtenstein_2018_Can.J.Neurol.Sci__1
PubMedSearch : Lichtenstein_2018_Can.J.Neurol.Sci__1
PubMedID: 29730995

Title : Predicting response to acetylcholinesterase inhibitor treatment in Alzheimer disease: has the time come? - Feldman_2009_Nat.Clin.Pract.Neurol_5_128
Author(s) : Feldman HH , Jacova C
Ref : Nat Clin Pract Neurol , 5 :128 , 2009
Abstract : Feldman_2009_Nat.Clin.Pract.Neurol_5_128
ESTHER : Feldman_2009_Nat.Clin.Pract.Neurol_5_128
PubMedSearch : Feldman_2009_Nat.Clin.Pract.Neurol_5_128
PubMedID: 19190589

Title : Treatment with galantamine and time to nursing home placement in Alzheimer's disease patients with and without cerebrovascular disease - Feldman_2009_Int.J.Geriatr.Psychiatry_24_479
Author(s) : Feldman HH , Pirttila T , Dartigues JF , Everitt B , Van Baelen B , Schwalen S , Kavanagh S
Ref : Int J Geriatr Psychiatry , 24 :479 , 2009
Abstract : Feldman_2009_Int.J.Geriatr.Psychiatry_24_479
ESTHER : Feldman_2009_Int.J.Geriatr.Psychiatry_24_479
PubMedSearch : Feldman_2009_Int.J.Geriatr.Psychiatry_24_479
PubMedID: 18985627

Title : Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease - Lane_2008_Pharmacogenet.Genomics_18_289
Author(s) : Lane R , Feldman HH , Meyer J , He Y , Ferris SH , Nordberg A , Darreh-Shori T , Soininen H , Pirttila T , Farlow MR , Sfikas N , Ballard C , Greig NH
Ref : Pharmacogenet Genomics , 18 :289 , 2008
Abstract : Lane_2008_Pharmacogenet.Genomics_18_289
ESTHER : Lane_2008_Pharmacogenet.Genomics_18_289
PubMedSearch : Lane_2008_Pharmacogenet.Genomics_18_289
PubMedID: 18334913

Title : Progress in clinical neurosciences: Canadian guidelines for the development of antidementia therapies: a conceptual summary - Feldman_2006_Can.J.Neurol.Sci_33_6
Author(s) : Feldman HH , Gauthier S , Chertkow H , Conn DK , Freedman M , Chris M
Ref : Can Journal of Neurology Sci , 33 :6 , 2006
Abstract : Feldman_2006_Can.J.Neurol.Sci_33_6
ESTHER : Feldman_2006_Can.J.Neurol.Sci_33_6
PubMedSearch : Feldman_2006_Can.J.Neurol.Sci_33_6
PubMedID: 16583717

Title : Mild cognitive impairment - Feldman_2005_Am.J.Geriatr.Psychiatry_13_645
Author(s) : Feldman HH , Jacova C
Ref : American Journal of Geriatry & Psychiatry , 13 :645 , 2005
Abstract : Feldman_2005_Am.J.Geriatr.Psychiatry_13_645
ESTHER : Feldman_2005_Am.J.Geriatr.Psychiatry_13_645
PubMedSearch : Feldman_2005_Am.J.Geriatr.Psychiatry_13_645
PubMedID: 16085780